These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12399188)

  • 21. Efficacy and long-term durability of intradermal recombinant hepatitis B virus vaccine among intramuscular vaccine nonresponders: A prospective study in healthcare personnel.
    Kalchiem-Dekel O; Grupel D; Bouchnik L; Sikuler E; Ben-Yakov G
    J Gastroenterol Hepatol; 2015 Dec; 30(12):1782-7. PubMed ID: 26101816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity of three recombinant hepatitis B vaccines administered to students in three doses containing half the antigen amount routinely used for adult vaccination.
    Baldy JL; de Lima GZ; Morimoto HK; Reiche EM; Matsuo T; de Mattos ED; Sudan LC
    Rev Inst Med Trop Sao Paulo; 2004; 46(2):103-7. PubMed ID: 15141282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The immune response of low dose recombinant DNA hepatitis B vaccine in teenagers in Singapore.
    Guan R; Tay HH; Yap I; Smith R; Tan LH
    Trans R Soc Trop Med Hyg; 1990; 84(5):731-2. PubMed ID: 2148992
    [No Abstract]   [Full Text] [Related]  

  • 24. Protective efficacy of hepatitis B vaccine without HBIG in infants of HBeAg-positive carrier mothers in Thailand.
    Lolekha S; Warachit B; Hirunyachote A; Bowonkiratikachorn P; West DJ; Poerschke G
    Vaccine; 2002 Nov; 20(31-32):3739-43. PubMed ID: 12399203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune response to an indigenously developed r-hepatitis B vaccine in mixed population: study of an accelerated vaccination schedule.
    Chowdhury A; Santra A; Habibullah CM; Khan AA; Karunakaramaiah J; Kishore TS; Raju AV; Lahiri S
    World J Gastroenterol; 2005 Feb; 11(7):1037-9. PubMed ID: 15742410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune response to intramuscular revaccination after primary intradermal vaccination against hepatitis B.
    Pegues DA; Woodruff BA; Lambert SB; Tant MK; Woernle CH
    Clin Infect Dis; 1995 Feb; 20(2):335-41. PubMed ID: 7742439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody responses to preS components after immunization of children with low doses of BioHepB.
    Madalinski K; Sylvan SP; Hellström U; Mikolajewicz J; Zembrzuska-Sadkowska E; Piontek E
    Vaccine; 2001 Oct; 20(1-2):92-7. PubMed ID: 11567751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Humoral immune response following hepatitis B vaccine booster dose in children with and without prior immunization.
    Chongsrisawat V; Theamboonlers A; Khwanjaipanich S; Owatanapanich S; Sinlaparatsamee S; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2000 Dec; 31(4):623-6. PubMed ID: 11414401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of hepatitis B vaccine in multi-transfused thalassemic patients with and without hepatitis C infection: a comparative study with healthy controls.
    Froutan-Pishbijari H; Ghofrani H; Mirmomenm S; Kazemi-Asl S; Nassiri-Toosi M; Farahvash MJ; Toroghi HH; Aminian K; Mansour-Ghanaei F; Bagherzadeh AH
    Med Sci Monit; 2004 Dec; 10(12):CR679-83. PubMed ID: 15567986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroconversion of Hepatitis B Vaccine in Young Children in the Kassena Nankana District of Ghana: A Cross-Sectional Study.
    Dassah S; Sakyi SA; Frempong MT; Luuse AT; Ephraim RK; Anto EO; Oduro A
    PLoS One; 2015; 10(12):e0145209. PubMed ID: 26716979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High seroprotection rate induced by low doses of a recombinant hepatitis B vaccine in healthy Iranian neonates.
    Shokri F; Jafarzadeh A
    Vaccine; 2001 Aug; 19(31):4544-8. PubMed ID: 11483282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
    Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
    HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized comparative trial of interferon-alpha versus placebo in hepatitis B vaccine non-responders and hyporesponders.
    Goldwater PN
    Vaccine; 1994 Apr; 12(5):410-4. PubMed ID: 8023548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric experience with recombinant hepatitis B vaccines and relevant safety and immunogenicity studies.
    Greenberg DP
    Pediatr Infect Dis J; 1993 May; 12(5):438-45. PubMed ID: 8327313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunogenicity of the Heberbiovac-HB vaccine in the physically and mentally handicapped].
    Pedroso Flaquet P; Díaz González M; Rodríguez Lay L; Bravo González JR
    Rev Cubana Med Trop; 1997; 49(1):59-63. PubMed ID: 9685963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anamnestic response to administration of purified non-adsorbed hepatitis B surface antigen in healthy responders to hepatitis B vaccine with long-term non-protective antibody titres.
    Dentico P; Crovari P; Lai PL; Ponzio F; Safary A; Pellegrino A; Meurice F; Di Pasquale A; Tornieporth N; Volpe A; Icardi G
    Vaccine; 2002 Nov; 20(31-32):3725-30. PubMed ID: 12399201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune memory and immune response in children from Bulgaria 5-15 years after primary hepatitis B vaccination.
    Teoharov P; Kevorkyan A; Petrova N; Baltadzhiev I; Van Damme P
    Pediatr Infect Dis J; 2013 Jan; 32(1):51-3. PubMed ID: 22914584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter study on the immunogenicity and safety of two recombinant vaccines against hepatitis B.
    Martins RM; Bensabath G; Arraes LC; Oliveira Mde L; Miguel JC; Barbosa GG; Camacho LA
    Mem Inst Oswaldo Cruz; 2004 Dec; 99(8):865-71. PubMed ID: 15761604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suitable hepatitis B vaccine for adult immunization in China: a systematic review and meta-analysis.
    Wu Z; Bao H; Yao J; Chen Y; Lu S; Li J; Jiang ZG; Ren JJ; Xu KJ; Ruan B; Yang SG; Xie TS; Hu Y
    Hum Vaccin Immunother; 2019; 15(1):220-227. PubMed ID: 30089437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.